Kestra Medical Technologies to Report Fourth Quarter Fiscal 2026 Financial Results on July 14
Kestra Medical Technologies (Nasdaq: KMTS) will report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS) will report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
Management will host a conference call at 4:30 p.m. Eastern Time, with a live and archived webcast available in the investor relations website’s Events section.
Positive
- None.
Negative
- None.
Details
News Market Reaction – KMTS
On Jul 1, the first trading day after this news, KMTS closed 3.30% above the previous close.
Data tracked by StockTitan Argus for the Jul 1 session.
Key Figures
- Earnings period
- Fourth quarter fiscal 2026
- Upcoming results to be reported
- Earnings release date
- July 14
- Q4 FY2026 results after market close
- Conference call time
- 4:30 p.m. Eastern Time
- Management discussion of Q4 FY2026 results
Previous Earnings date Reports
-
Company scheduled Q3 FY2026 earnings release and post-close conference call.
-
Company announced Q2 FY2026 results date and investor conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
webcast technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., June 30, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, is scheduled to report fourth quarter fiscal 2026 financial results after the market closes on Tuesday, July 14.
Management will host a conference call at 4:30 p.m. Eastern Time to discuss financial results. A live and archived webcast of the conference call will be available in the “Events” section of the investor relations website.
About Kestra
Kestra Medical Technologies, Ltd. is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, visit www.kestramedical.com.

Investor contact Neil Bhalodkar neil.bhalodkar@kestramedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.